TC
RMD icon

Truvestments Capital’s ResMed RMD Stock Holding History

Truvestments Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3K Hold
58
– – ﹤0.01% 778
2026
Q1 		$13K Hold
58
– – ﹤0.01% 716
2025
Q4 		$14K Hold
58
– – ﹤0.01% 647
2025
Q3 		$15.9K Buy
+58
New +$15.8K ﹤0.01% 639
2024
Q1 		– Sell
-100
Closed -$17.2K – 844
2023
Q4 		$17.2K Hold
100
– – 0.01% 462
2023
Q3 		$14.8K Hold
100
– – 0.01% 414
2023
Q2 		$21.9K Hold
100
– – 0.01% 372
2023
Q1 		$21.9K Hold
100
– – 0.01% 366
2022
Q4 		$20.8K Hold
100
– – 0.01% 380
2022
Q3 		$22K Buy
+100
New +$22.8K 0.01% 334

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Truvestments Capital's RMD Position: Q2 2026 in Review

Truvestments Capital held its ResMed (RMD) position steady in Q2 2026 at 58 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #778.

Truvestments Capital first reported a position in RMD in Q3 2022 and has held it in 10 quarters since. The position peaked at $22K in Q3 2022. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Truvestments Capital held 58 shares of ResMed worth $11.3K as of Q2 2026.
  • Truvestments Capital left its ResMed share count unchanged in Q2 2026.
  • ResMed made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #778 holding.
  • Truvestments Capital first reported a position in ResMed in Q3 2022 and has held it in 10 quarters since.
  • Truvestments Capital's ResMed position peaked at $22K in Q3 2022.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.